We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Toraphene is an environmental technology company that aims to eliminate plastic waste. It has released with its product, Toraphene, to solve this crisis. It claims that Toraphene is a biodegradable, compostable and commercially-viable plastic packaging substitute for conventional plastic. The company asserts that its product is biodegradable even in the ocean, and has been developed using graphene technology. It is focussed on eliminating carrier bags and food containers in its first-round which account for 23% of marine waste. It aims to be a segment leader in the projected $25.4 billion biodegradable plastic industry by 2026. The company will use the investment to make Toraphene accessible to companies worldwide and make plastic packaging obsolete.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,000,000
Glint is a proprietary multi-currency platform that allows users to buy, save, spend and send real gold and other currencies, digitally with its application. The company asserts that its scalable technology enables its clients to use their currencies such as GBP, USD, EUR and Gold, with Glint's UK, EU and US-issued Mastercards in 210 countries worldwide. Glint also points out that its Peer-to-Peer (P2P) Service, Glint It!, allows clients to send and receive gold and currency between Glint accounts in over 160 countries. The company has raised £20 million in equity funding to date, reached 79,000 registered clients, and overseen over £158 million worth of transactions on its platform. Glint will use the investment to maximise revenue, organically grow its business, increase its registered customer base to 250,000 in 2021, and hire key personnel across various portfolios.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £3,072,539
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,646,249
HaMuch is an online platform that lets homeowners compare hourly rates of local tradespeople and check their availability. The company has provided digital marketing services to businesses such as Travis Perkins, HomeServe, and Rated People. About 200,000 tradespeople have uploaded their profiles on the platform with 12,000+ having uploaded their respective prices. The company has been featured in The Sunday Telegraph, Express, Sun, and Microsoft News. 

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £132,850
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
Lifetise is a financial planning platform that enables prospective clients to plan significant expenditures such as buying a home, marital expenses, child-rearing and retirement. Presently, they have come up with two major offerings: Homefinder and Childminder. The first one acts as a tool that shows money required to afford a home in the UK and the amount of time taken to save the money while the latter helps parents to calculate the costs of childcare along with their work. Lifetise is targeting the 25-40 age group in the UK whose population numbers are approximately 14 million. To date, they have been featured in prominent publications like Evening Standard and Stylist with an active following on Reddit. The company has secured 12,000 customers after their partnering with Accenture's Fintech Accelerator Programme. With the investment, Lifetise will spend more on developing its applications with a focus on all major life expenditures, marketing on social media channels, build partnerships and human resources.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £254,240
YoungPlanet enables parents to put their children's unused things to use with new families and away from landfills for free via its app. The company cites PwC data estimating the UK’s sharing economy to be worth £9 billion by 2025. It aims to be a contender in this segment. The company argues further that 10-year-olds in the UK will own on average 238 toys at any one time and yet play with just 12. This leads to UK households wasting over 25 million tonnes a year, with one-fourth of this number ending up in landfills as per the Department for Environment, Food and Rural Affairs (DEFRA). YoungPlanet aims to change this. It has onboarded 36,000 users on its platform to date and featured in press publications such as BBC News, Vanessa Feltz, and LadBible. YoungPlanet will use the investment to scale nationally, begin generating first phase revenue via brand sponsorship of events, branded gamification, and Business-to-Business (B2B) subscriptions for semi-closed communities via its app.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £547,103
Equipsme is a company that aims to democratise health insurance by making it affordable for businesses. The company offers flexible fixed-price packages to employees while giving them the option to upgrade their package to avail more features upon payment. Members can speak to a general physician round the clock, have physiotherapy sessions, avail regular health checks and, if necessary, be quickly referred to a consultant for diagnosis and treatment. Members can access these features through a simple-to-use application. Since February 2018, the company has secured an exclusive 5-year insurance capacity deal with AXA PPP Healthcare and grown its members by 130.5% Year-on-Year (YoY) (to May 2020) with a 95% broker renewal retention rate. The company will use the investment to enhance its user experience and scale its marketing as it announces its partnerships with organisations such as Starling Bank and Simply Business.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £879,204
Span Health is a digital care platform that aims to help people avoid lifestyle-induced diseases, symptoms, medication, and complications. The company has helped more than 10,000 people to live a better and longer life. Span Health's easy-to-use mobile application allows patients to chat with clinicians, order blood tests at home, book video consultations, and see results in the application itself. Moreover, in 2019, the company agreed on a National Health Service (NHS) pilot test for 100 patients in collaboration with the National Institute of Health Research in North West London. Span Health will use the investment to provide employees with blood tests to screen for health risk factors and recover from detected illness safely and sustainably, improve its platform data insights, prediction and machine learning to better structure the clinician's processes, and further reduce its operational costs.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £134,892
Square Mile Farms (SMF) is a company that installs innovative and productive vertical farms in a workplace to engage employees and help businesses create a culture of healthy, low-impact living. Its 'Office Farming' model creates green spaces for engagement and collaboration. In 2019, it was invited to build a vertical farm in Paddington Central by British Land, one of UK’s largest landowners. The setup now acts as a hub for the company's office farm installations and a base from which it can conduct Research and Development (R&D). SMF's customers include Grosvenor Group Limited and Vodafone. Moreover, the company has been covered by media platforms such as BBC One and BBC Radio. It will use 45% of the investment for sales and business development, 15% for design and technology up-gradation, 15% for raising its profile and increasing brand awareness, and 25% for operations.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £504,118
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph